306 related articles for article (PubMed ID: 17572194)
1. Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005.
Makarov DV; Trock BJ; Humphreys EB; Mangold LA; Walsh PC; Epstein JI; Partin AW
Urology; 2007 Jun; 69(6):1095-101. PubMed ID: 17572194
[TBL] [Abstract][Full Text] [Related]
2. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium.
Partin AW; Mangold LA; Lamm DM; Walsh PC; Epstein JI; Pearson JD
Urology; 2001 Dec; 58(6):843-8. PubMed ID: 11744442
[TBL] [Abstract][Full Text] [Related]
3. An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011.
Eifler JB; Feng Z; Lin BM; Partin MT; Humphreys EB; Han M; Epstein JI; Walsh PC; Trock BJ; Partin AW
BJU Int; 2013 Jan; 111(1):22-9. PubMed ID: 22834909
[TBL] [Abstract][Full Text] [Related]
4. Prediction of pathological stage based on clinical stage, serum prostate-specific antigen, and biopsy Gleason score: Partin Tables in the contemporary era.
Tosoian JJ; Chappidi M; Feng Z; Humphreys EB; Han M; Pavlovich CP; Epstein JI; Partin AW; Trock BJ
BJU Int; 2017 May; 119(5):676-683. PubMed ID: 27367645
[TBL] [Abstract][Full Text] [Related]
5. Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason score.
Huang Y; Isharwal S; Haese A; Chun FK; Makarov DV; Feng Z; Han M; Humphreys E; Epstein JI; Partin AW; Veltri RW
BJU Int; 2011 May; 107(10):1562-9. PubMed ID: 20875091
[TBL] [Abstract][Full Text] [Related]
6. Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer.
Naito S; Kuroiwa K; Kinukawa N; Goto K; Koga H; Ogawa O; Murai M; Shiraishi T;
J Urol; 2008 Sep; 180(3):904-9; discussion 909-10. PubMed ID: 18635221
[TBL] [Abstract][Full Text] [Related]
7. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update.
Partin AW; Kattan MW; Subong EN; Walsh PC; Wojno KJ; Oesterling JE; Scardino PT; Pearson JD
JAMA; 1997 May; 277(18):1445-51. PubMed ID: 9145716
[TBL] [Abstract][Full Text] [Related]
8. Complexed prostate-specific antigen as a staging tool for prostate cancer: a prospective study in 420 men.
Sokoll LJ; Mangold LA; Partin AW; Epstein JI; Bruzek DJ; Dunn W; Mohr P; Wallerson G; Chan DW
Urology; 2002 Oct; 60(4 Suppl 1):18-23. PubMed ID: 12384158
[TBL] [Abstract][Full Text] [Related]
9. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.
Freedland SJ; Presti JC; Terris MK; Kane CJ; Aronson WJ; Dorey F; Amling CL;
J Urol; 2003 Jun; 169(6):2129-35. PubMed ID: 12771734
[TBL] [Abstract][Full Text] [Related]
10. The role of transrectal ultrasound-guided biopsy-based staging, preoperative serum prostate-specific antigen, and biopsy Gleason score in prediction of final pathologic diagnosis in prostate cancer.
Narayan P; Gajendran V; Taylor SP; Tewari A; Presti JC; Leidich R; Lo R; Palmer K; Shinohara K; Spaulding JT
Urology; 1995 Aug; 46(2):205-12. PubMed ID: 7542823
[TBL] [Abstract][Full Text] [Related]
11. Validation of 2001 Partin tables in Turkey: a multicenter study.
Eskicorapci SY; Karabulut E; Türkeri L; Baltaci S; Cal C; Toktas G; Akpinar H; Ozer G; Sozen S; Tokuc R; Lekili M; Soylu A; Albayrak S; Sahin H; Alpar R; Ozen H
Eur Urol; 2005 Feb; 47(2):185-9. PubMed ID: 15661412
[TBL] [Abstract][Full Text] [Related]
12. A new nomogram to predict pathologic outcome following radical prostatectomy.
Crippa A; Srougi M; Dall'Oglio MF; Antunes AA; Leite KR; Nesrallah LJ; Ortiz V
Int Braz J Urol; 2006; 32(2):155-64. PubMed ID: 16650292
[TBL] [Abstract][Full Text] [Related]
13. Nomograms to predict the pathological stage of clinically localized prostate cancer in Korean men: comparison with western predictive tools using decision curve analysis.
Jeong CW; Jeong SJ; Hong SK; Lee SB; Ku JH; Byun SS; Jeong H; Kwak C; Kim HH; Lee E; Lee SE
Int J Urol; 2012 Sep; 19(9):846-52. PubMed ID: 22587373
[TBL] [Abstract][Full Text] [Related]
14. Probability of biochemical recurrence by analysis of pathologic stage, Gleason score, and margin status for localized prostate cancer.
Khan MA; Partin AW; Mangold LA; Epstein JI; Walsh PC
Urology; 2003 Nov; 62(5):866-71. PubMed ID: 14624910
[TBL] [Abstract][Full Text] [Related]
15. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer.
Blute ML; Bergstralh EJ; Partin AW; Walsh PC; Kattan MW; Scardino PT; Montie JE; Pearson JD; Slezak JM; Zincke H
J Urol; 2000 Nov; 164(5):1591-5. PubMed ID: 11025711
[TBL] [Abstract][Full Text] [Related]
16. Validation of the partin nomogram for prostate cancer in a national sample.
Yu JB; Makarov DV; Sharma R; Peschel RE; Partin AW; Gross CP
J Urol; 2010 Jan; 183(1):105-11. PubMed ID: 19913246
[TBL] [Abstract][Full Text] [Related]
17. Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer.
Rayn KN; Bloom JB; Gold SA; Hale GR; Baiocco JA; Mehralivand S; Czarniecki M; Sabarwal VK; Valera V; Wood BJ; Merino MJ; Choyke P; Turkbey B; Pinto PA
J Urol; 2018 Nov; 200(5):1041-1047. PubMed ID: 29852182
[TBL] [Abstract][Full Text] [Related]
18. One-Stop-Shop Whole-Body
Thalgott M; Düwel C; Rauscher I; Heck MM; Haller B; Gafita A; Gschwend JE; Schwaiger M; Maurer T; Eiber M
J Nucl Med; 2018 Dec; 59(12):1850-1856. PubMed ID: 29794224
[TBL] [Abstract][Full Text] [Related]
19. Are prostate carcinoma clinical stages T1c and T2 similar?
Billis A; Magna LA; Watanabe IC; Costa MV; Telles GH; Ferreira U
Int Braz J Urol; 2006; 32(2):165-71. PubMed ID: 16650293
[TBL] [Abstract][Full Text] [Related]
20. Can Radiologic Staging With Multiparametric MRI Enhance the Accuracy of the Partin Tables in Predicting Organ-Confined Prostate Cancer?
Gupta RT; Brown AF; Silverman RK; Tay KJ; Madden JF; George DJ; Polascik TJ
AJR Am J Roentgenol; 2016 Jul; 207(1):87-95. PubMed ID: 27064383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]